Canada Life’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-127
Closed -$12K 2441
2022
Q1
$12K Buy
127
+29
+30% +$3.94K ﹤0.01% 2411
2021
Q4
$21K Buy
98
+29
+42% +$8.1K ﹤0.01% 2371
2021
Q3
$24K Hold
69
﹤0.01% 2393
2021
Q2
$26K Hold
69
﹤0.01% 2434
2021
Q1
$21K Sell
69
-94
-58% -$32.9K ﹤0.01% 2496
2020
Q4
$41K Hold
163
﹤0.01% 2352
2020
Q3
$30K Hold
163
﹤0.01% 2326
2020
Q2
$41K Buy
+163
New +$35.7K ﹤0.01% 2277

Other funds holding DTIL

Canada Life's DTIL Position: Q2 2022 in Review

Canada Life sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 127 shares — an estimated $12K sold.

Canada Life first reported a position in DTIL in Q2 2020 and held it in 8 quarters. The position peaked at $41K in Q4 2020. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Canada Life reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 127 Precision BioSciences shares in Q2 2022, an estimated $12K.
  • Canada Life first reported a position in Precision BioSciences in Q2 2020 and held it in 8 quarters.
  • Canada Life's Precision BioSciences position peaked at $41K in Q4 2020.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.